BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Korac-Prlic J, Degoricija M, Vilović K, Haupt B, Ivanišević T, Franković L, Grivennikov S, Terzić J. Targeting Stat3 signaling impairs the progression of bladder cancer in a mouse model. Cancer Lett 2020;490:89-99. [PMID: 32659249 DOI: 10.1016/j.canlet.2020.06.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Nitschke K, Worst TS, von Rhade SM, Thaqi B, Neuberger M, Wessels F, Weis CA, Porubsky S, Gaiser T, Kriegmair M, von Hardenberg J, Weidenbusch M, Erben P, Nuhn P. High IL-22RA1 gene expression is associated with poor outcome in muscle invasive bladder cancer. Urol Oncol 2021;39:499.e1-8. [PMID: 34134925 DOI: 10.1016/j.urolonc.2021.05.010] [Reference Citation Analysis]
2 Martin A, Woolbright BL, Umar S, Ingersoll MA, Taylor JA 3rd. Bladder cancer, inflammageing and microbiomes. Nat Rev Urol 2022. [PMID: 35798831 DOI: 10.1038/s41585-022-00611-3] [Reference Citation Analysis]
3 Na L, Wang Z, Bai Y, Sun Y, Dong D, Wang W, Zhao C. WNT7B represses epithelial-mesenchymal transition and stem-like properties in bladder urothelial carcinoma. Biochim Biophys Acta Mol Basis Dis 2021;1868:166271. [PMID: 34562599 DOI: 10.1016/j.bbadis.2021.166271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Korac-Prlic J, Degoricija M, Vilović K, Vujević S, Terzić J. BBN-driven urinary bladder cancer mouse model. Methods Cell Biol 2021;163:77-92. [PMID: 33785170 DOI: 10.1016/bs.mcb.2020.10.020] [Reference Citation Analysis]
5 Mohammad Mirzaei N, Changizi N, Asadpoure A, Su S, Sofia D, Tatarova Z, Zervantonakis IK, Chang YH, Shahriyari L. Investigating key cell types and molecules dynamics in PyMT mice model of breast cancer through a mathematical model. PLoS Comput Biol 2022;18:e1009953. [PMID: 35294447 DOI: 10.1371/journal.pcbi.1009953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chen M, Zhang R, Lu L, Du J, Chen C, Ding K, Wei X, Zhang G, Huang Y, Hou J. LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA. Aging (Albany NY) 2020;12:22291-312. [PMID: 33188158 DOI: 10.18632/aging.202203] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
7 Mohammad Mirzaei N, Tatarova Z, Hao W, Changizi N, Asadpoure A, Zervantonakis IK, Hu Y, Chang YH, Shahriyari L. A PDE Model of Breast Tumor Progression in MMTV-PyMT Mice. JPM 2022;12:807. [DOI: 10.3390/jpm12050807] [Reference Citation Analysis]
8 Sionov RV. Leveling Up the Controversial Role of Neutrophils in Cancer: When the Complexity Becomes Entangled. Cells 2021;10:2486. [PMID: 34572138 DOI: 10.3390/cells10092486] [Reference Citation Analysis]
9 Xia Y, Chen S, Cui J, Wang Y, Liu X, Shen Y, Gong L, Jiang X, Wang W, Zhu Y, Sun S, Li J, Zou Y, Shi B. Berberine suppresses bladder cancer cell proliferation by inhibiting JAK1-STAT3 signaling via upregulation of miR-17-5p. Biochem Pharmacol 2021;188:114575. [PMID: 33887260 DOI: 10.1016/j.bcp.2021.114575] [Reference Citation Analysis]
10 Moghadam ER, Ang HL, Asnaf SE, Zabolian A, Saleki H, Yavari M, Esmaeili H, Zarrabi A, Ashrafizadeh M, Kumar AP. Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives. Biomolecules 2020;10:E1374. [PMID: 32992587 DOI: 10.3390/biom10101374] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
11 Liu J, Zheng Z, Zhang W, Wan M, Ma W, Wang R, Yan Y, Guo Y, Zhang J, Li W, Yao X. Dysregulation of tumor microenvironment promotes malignant progression and predicts risk of metastasis in bladder cancer. Ann Transl Med 2021;9:1438. [PMID: 34733990 DOI: 10.21037/atm-21-4023] [Reference Citation Analysis]
12 Yang F, Liu X, He J, Xian S, Yang P, Mai Z, Li M, Liu Y, Zhang X. Occludin facilitates tumour angiogenesis in bladder cancer by regulating IL8/STAT3 through STAT4. J Cellular Molecular Medi. [DOI: 10.1111/jcmm.17257] [Reference Citation Analysis]
13 Wang G, Dai Y, Li K, Cheng M, Xiong G, Wang X, Chen S, Chen Z, Chen J, Xu X, Ling RS, Peng L, Chen D. Deficiency of Mettl3 in Bladder Cancer Stem Cells Inhibits Bladder Cancer Progression and Angiogenesis. Front Cell Dev Biol 2021;9:627706. [PMID: 33681207 DOI: 10.3389/fcell.2021.627706] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Mirzaei S, Gholami MH, Mahabady MK, Nabavi N, Zabolian A, Banihashemi SM, Haddadi A, Entezari M, Hushmandi K, Makvandi P, Samarghandian S, Zarrabi A, Ashrafizadeh M, Khan H. Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation. Biomed Pharmacother 2021;133:111077. [PMID: 33378975 DOI: 10.1016/j.biopha.2020.111077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Taniyama D, Sakamoto N, Takashima T, Takeda M, Pham QT, Ukai S, Maruyama R, Harada K, Babasaki T, Sekino Y, Hayashi T, Sentani K, Pommier Y, Murai J, Yasui W. Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum-based chemotherapy. Cancer Sci 2021. [PMID: 34808009 DOI: 10.1111/cas.15207] [Reference Citation Analysis]